These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15986143)

  • 1. Immunological detection of altered signaling molecules involved in melanoma development.
    Kawakami Y; Sumimoto H; Fujita T; Matsuzaki Y
    Cancer Metastasis Rev; 2005 Jun; 24(2):357-66. PubMed ID: 15986143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An immunocytochemical investigation of antigen expression by skin melanoma cells cultured for vaccine production].
    Moiseenko VM; Danilova AB; Danilov AO; Turkevich EA; Baldueva IA; Matsko DE
    Vopr Onkol; 2008; 54(3):303-14. PubMed ID: 18652234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting STAT3 affects melanoma on multiple fronts.
    Kortylewski M; Jove R; Yu H
    Cancer Metastasis Rev; 2005 Jun; 24(2):315-27. PubMed ID: 15986140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
    J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell recognition of melanoma-associated antigens.
    Castelli C; Rivoltini L; Andreola G; Carrabba M; Renkvist N; Parmiani G
    J Cell Physiol; 2000 Mar; 182(3):323-31. PubMed ID: 10653598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of advanced or metastatic melanoma.
    Cebon J; Gedye C; John T; Davis ID
    Clin Adv Hematol Oncol; 2007 Dec; 5(12):994-1006. PubMed ID: 18277962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immuno-diagnosis of malignant melanoma].
    Szekeres G; Battyáni Z
    Magy Onkol; 2003; 47(1):45-50. PubMed ID: 12704454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-infiltrating lymphocytes and melanoma tumorigenesis: an insight.
    Hussein MR
    Br J Dermatol; 2005 Jul; 153(1):18-21. PubMed ID: 16029321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma.
    Ohnmacht GA; Marincola FM
    J Cell Physiol; 2000 Mar; 182(3):332-8. PubMed ID: 10653599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and functional analysis of CD8+ T cells specific for PRAME: a target for T-cell therapy.
    Griffioen M; Kessler JH; Borghi M; van Soest RA; van der Minne CE; Nouta J; van der Burg SH; Medema JP; Schrier PI; Falkenburg JH; Osanto S; Melief CJ
    Clin Cancer Res; 2006 May; 12(10):3130-6. PubMed ID: 16707612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts of tumor-infiltrating lymphocytes in human malignancies.
    Chiou SH; Sheu BC; Chang WC; Huang SC; Hong-Nerng H
    J Reprod Immunol; 2005 Oct; 67(1-2):35-50. PubMed ID: 16111767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel strategy for the discovery of MHC class II-restricted tumor antigens: identification of a melanotransferrin helper T-cell epitope.
    Röhn TA; Reitz A; Paschen A; Nguyen XD; Schadendorf D; Vogt AB; Kropshofer H
    Cancer Res; 2005 Nov; 65(21):10068-78. PubMed ID: 16267033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma vaccines.
    Chapman PB
    Semin Oncol; 2007 Dec; 34(6):516-23. PubMed ID: 18083375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment.
    Gajewski TF
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5256-61. PubMed ID: 17875753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R
    Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma.
    van Houdt IS; Oudejans JJ; van den Eertwegh AJ; Baars A; Vos W; Bladergroen BA; Rimoldi D; Muris JJ; Hooijberg E; Gundy CM; Meijer CJ; Kummer JA
    Clin Cancer Res; 2005 Sep; 11(17):6400-7. PubMed ID: 16144945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo detectable human CD8 T-cell responses to cancer-testis antigens.
    Baumgaertner P; Rufer N; Devevre E; Derre L; Rimoldi D; Geldhof C; Voelter V; Liénard D; Romero P; Speiser DE
    Cancer Res; 2006 Feb; 66(4):1912-6. PubMed ID: 16488988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell distribution and adhesion receptor expression in metastatic melanoma.
    Weishaupt C; Munoz KN; Buzney E; Kupper TS; Fuhlbrigge RC
    Clin Cancer Res; 2007 May; 13(9):2549-56. PubMed ID: 17473183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
    Gu L; Chiang KY; Zhu N; Findley HW; Zhou M
    Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.